{
  "meta": {
    "title": "Galactosemia_Hereditary_Fructose_Intolerance",
    "url": "https://brainandscalpel.vercel.app/galactosemia-hereditary-fructose-intolerance-700708b8.html",
    "scrapedAt": "2025-11-29T18:33:00.358Z"
  },
  "questions": [
    {
      "id": 16484,
      "choices": [
        {
          "id": 65896,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-iii,2-iv,3-i,4-ii</span></span></span></p>"
        },
        {
          "id": 65897,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-iv,2-iii,3-I,4-ii</span></span></span></p>"
        },
        {
          "id": 65898,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-i,2-iv,3-ii,4-iii</span></span></span></p>"
        },
        {
          "id": 65899,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-ii,2-iv,3-I,4-iii</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A paediatric resident is reviewing metabolic disorders for an upcoming exam and is focusing on enzyme deficiencies associated with various paediatric diseases. Match the following paediatric diseases with their corresponding enzyme deficiencies:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture13.jpg\" style=\"height:165px; width:700px\" /></p>",
      "unique_key": "Q9344520",
      "question_audio": null,
      "question_video": null,
      "map_id": 33057,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1-iii, 2-iv, 3-I ,4-ii</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"margin-left:24px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alkaptonuria is caused by a deficiency in homogentisic acid oxidase </strong>(iii), leading to the <strong>accumulation of homogentisic acid</strong>, which causes <strong>darkening of urine </strong>and <strong>potentially arthritic complications.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phenylketonuria </strong>results from a <strong>deficiency in phenylalanine hydroxylase </strong>(iv), which leads to <strong>elevated levels of phenylalanine in the blood </strong>and can <strong>cause intellectual disability if untreated.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tyrosinemia </strong>(Type I) is due to a <strong>deficiency in fumarylacetoacetate hydrolase </strong>(i), resulting in <strong>liver and kidney dysfunction</strong>, along with a <strong>cabbage-like odor</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Richner-Hanhart syndrome </strong>(Tyrosinemia Type II) is associated with a <strong>deficiency in tyrosine transaminase </strong>(ii), leading to <strong>painful palmoplantar keratoderma </strong>and <strong>corneal ulcers</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/24/screenshot-2024-05-24-183613.JPG\" style=\"height:205px; width:827px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Nelson 21<sup>st</sup> Edition, Chapter 103.</span></strong></span></span></p>",
      "correct_choice_id": 65896,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16457,
      "choices": [
        {
          "id": 65788,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate dehydrogenase complex (PDC)</span></span></span></p>"
        },
        {
          "id": 65789,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate kinase deficiency</span></span></span></p>"
        },
        {
          "id": 65790,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphate dehydrogenase deficiency</span></span></span></p>"
        },
        {
          "id": 65791,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-Phosphatase deficiency</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 12-year-old boy presents with fever, chills, abdominal pain, and diarrhea in a malaria-prevalent area. Following a positive rapid antigen test for malaria, he is started on Primaquine therapy. Four days into treatment, he develops hematuria, with his hemoglobin level dropping from 11.3 g/dL to 7.12 g/dL, total bilirubin rising from 1.38 mg/dL to 4.52 mg/dL, and lactate dehydrogenase (LDH) increasing from 236 IU/L to 509 IU/L. What is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q6588427",
      "question_audio": null,
      "question_video": null,
      "map_id": 33056,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Glucose-6-phosphate dehydrogenase deficiency</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient is most probably suffering from G6PD deficiency. The hemolysis is primaquine induced which is an oxidant drug. The rise in bilirubin is due to hemolytic jaundice and The rise in lactic dehydrogenase (LDH) is commonly observed in hemolytic anemias. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">X-linked Recessive </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Asymptomatic </strong>until their RBC are exposed to certain chemicals in food or medicine, or to stress.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dark urine </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enlarged spleen </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatigue </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pallor </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rapid heart rate </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Shortness of breath </span></span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Jaundice.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis; <strong>Bite cells</strong> on PS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Screening: Qualitative assessment of G6PD enzymatic activity (UV-based test)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Confirmatory test: Quantitative measurement of G6PD enzymatic activity </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Molecular test: Detection of G6PD gene mutation</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Pyruvate dehydrogenase complex (PDC) deficiency:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This metabolic disorder primarily affects the neurological system and is not associated with drug-induced hemolysis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Pyruvate kinase deficiency:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While this enzyme deficiency can cause hemolytic anemia, it is less likely to be triggered by Primaquine therapy compared to G6PD deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Glucose-6-Phosphatase deficiency:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This condition is related to glycogen storage disease type I and presents with metabolic issues rather than acute hemolytic anemia triggered by medication.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primaquine and other oxidative drugs can precipitate hemolysis in individuals with G6PD deficiency, as seen in this case with the sudden drop in hemoglobin, increase in total bilirubin, and rise in LDH levels, which are markers of hemolysis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Nelson 21<sup>st</sup> edition, Chapter 490 &ndash; Page No 10068-10069</span></strong></span></span></p>",
      "correct_choice_id": 65790,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}